CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
December 22, 2022 16:00 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
November 16, 2022 00:00 ET
|
Alvotech
Revenue for first nine months of 2022 increased to $59.2 million, compared to $2.0 million for the same period in 2021 Discussions with U.S. FDA progressed regarding both biologic license...
Alvotech kynnir uppgjör fyrir fyrstu níu mánuði ársins 2022 og skýrir frá helstu áföngum í rekstri
November 15, 2022 23:55 ET
|
Alvotech
Tekjur fyrstu níu mánuði ársins voru 8,7 milljarðar króna samanborið við 291 milljón króna á sama tímabili í fyrraViðræður héldu áfram við Bandaríska lyfjaeftirlitið (FDA) um meðferð beggja umsókna um...
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
November 15, 2022 23:55 ET
|
Alvotech
Revenue for first nine months of 2022 increased to $59.2 million, compared to $2.0 million for the same period in 2021Discussions with U.S. FDA progressed regarding both biologic license applications...
Broadwind Announces Third Quarter 2022 Results
November 08, 2022 07:00 ET
|
Broadwind
CICERO, Ill., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today...
ARCA biopharma Announces Third Quarter 2022 Financial Results
October 28, 2022 16:15 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Oct. 28, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
Alvotech mun birta uppgjör fyrir fyrstu níu mánuði ársins 2022 þann 15. nóvember og heldur kynningarfund 16. nóvember
October 27, 2022 17:00 ET
|
Alvotech
Alvotech mun birta uppgjör fyrir fyrstu níu mánuði ársins 2022, eftir lokun markaða í Bandaríkjunum þriðjudaginn 15. nóvember n.k. Kynningarfundur fyrir markaðsaðila verður haldinn í beinu streymi...
Alvotech to Report First Nine Months Financial Results on November 15, 2022 and Host Business Update Conference Call at 8:00 am ET on November 16, 2022
October 27, 2022 17:00 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results...
Alvotech to Report First Nine Months Financial Results on November 15, 2022 and Host Business Update Conference Call at 8:00 am ET on November 16, 2022
October 27, 2022 17:00 ET
|
Alvotech
REYKJAVIK, Iceland, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide,...
Visteon Announces Third-Quarter 2022 Results
October 27, 2022 06:55 ET
|
Visteon Corporation
VAN BUREN TOWNSHIP, Mich., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today reported third quarter 2022 financial results. Highlights include: Sales of $1,026 million,...